ABSTRACT
INTRODUCTION
Besides complications like cardiovascular changes, nephropathy and neuropathy, diabetic retinopathy (DR) is a common complication of both Type I and Type II diabetes mellitus (DM). Diabetic retinopathy is the most severe of the several ocular complications of diabetes. Advances in treatment over the post 40 years have greatly reduced the risk of blindness from this disease. However, as diabetes is so common that retinopathy remains an important problem (1) . Blindness, like other complications of diabetes, is usually caused by persistent high blood glucose level damaging blood vessels. DR is the leading cause of blindness in people between 20 and 74 years of age (1, 2, 3) . Of all the complications of diabetes mellitus, DR and age related macular degeneration (AMD) are most prevalent in the Western World. In India, it was the seventeenth cause of blindness twenty years ago. Today the diabetes related blindness has rapidly ascended to the sixth position (4, 5) . DR is a progressive disease that passes through following stages, (1) no apparent DR, (11) nonproliferative DR, (111) proliferative (DR) and (18) vitreous hemorrhage resulting in poor visual acuity. Non-proliferative DR is characterized by the presence of venous dilatation, microaneurysm formation, retinal hemorrhage, retinal edema, and hard exudates (4). The incidence of DR was found significantly high in the Hispanic (especially Cuban, Mexican) diabetic patients surveyed in the third National Health and Nutrition Examination Survey (NHANES 111) (6) . Improved control of blood -glucose level, retards progression of diabetic microvascular disease, but the effect on macrovascular complication is unknown (7) . The benefits of improved glycemic and lipid control on complications of DM are now almost confirmed. Enhanced oxidative stress along with decreased antioxidative status causes progression of the disease. Antioxidant defenses are located both inside and outside the cell. The benefits of antioxidant on delaying development of complication are also reported. Vitamin E (D-tocopherol), a chain-breaking lipid soluble antioxidant, has been used in medicine in the treatment of cataract, arteriosclerosis, cancer, tardive dyskinesia, immunological and hematological disorders and peripheral neuropathy (8) . Heart disease is the leading cause of diabetes related death because chronically elevated blood sugar level is associated with arteriosclerosis, hypertriglyceridema, decreased HDL level, hypertension and heart attack (9). However, there is no study assessing its effect on DR. Currently available therapeutic options for non-insulin-dependent diabetes mellitus (NIDDM) such as dietary modification, oral hypoglycemic drugs and insulin have limitations of their own. A diet with plenty of fruits, nuts, grains and vegetables is rich in vitamin-E and has remarkable antioxidant effects (10) . These effects seem to protect the organs from stressful effect of hyperglycemia. Plants have always been the source of drugs since ancient time. Many of the currently available drugs have been derived directly or indirectly from plants. Many herbal medicines have been recommended for the treatment of diabetes. Tulsi (Ocimum sanctum-family Lamiaceae Linde) is one of such drugs, used in diabetes mellitus. The effect of Ocimum sanctum (Tulsi) on the plasma glucose, serum lipid, peroxidase and antioxidant enzymes are documented (11, 12) . However, the effect of Tulsi and vitamin E individually or in combination on diabetic retinopathy has not been studied earlier. The present study is aimed to demonstrate the effect of Tulsi and vitamin E on biochemical parameters as well as on welldeveloped retinopathy in diabetic male albino rat.
MATERIALS AND METHODS I. Animals: Diabetic and Control
Healthy adult Male Wistar albino rats of 150-200 gram weight were used for the study. They were fed with a standard diet and water ad libitum. Twenty-five rats were made diabetic by intraperitoneal injection of streptozotocin (STZ), 60 mg/kg dissolved in citrate buffer at pH 6.3. Five rats were injected with same volume of only citrate buffer and were used as non-diabetic healthy controls. The diabetic rats developed changes in their retina and developed diabetic retinopathy after one month. The diabetic rats were divided into following four groups, each having five rats. Five diabetic rats, which expired during the experiment, were excluded from the study. During the course of the experiment, the animals were fed with standard pellet diet ad libitum and had free access to water (12) . All the animals were cared according to the rules and regulations of the Institutional Animal Ethics Committee (IAEC) guidelines of Jamia Hamdard University, New Delhi where the animals were reared (First author's earlier place of work).
II . Streptozoticin, Vitamin E and Aqueous extract of Tulsi
Streptozotocin (STZ) and capsule of Vitamin E (544 mg) were obtained from Sigma, USA. Tulsi leaves were collected from Indian Agriculture Research Institute New Delhi. Identification was done from National Bureau of Plant Genetic Research (NBPGR), Pusa Campus, New Delhi. Ocimum santum collected belongs to family Lamiaceae Lindi and has purple leaves (photograph submitted). The leaves were air dried at room temperature and powdered in a grinder. An aqueous extract was produced by soaking the powdered leaves in distilled water at room temperature for 24 hours. After adequate stirring the mixture was centrifuged and filtered. The supernatant was collected and processed as described earlier (10). The supernatant was lyophilized in lyophilizer and the extract was reconstituted in sterile water at room temperature. The rats were fed with reconstituted extract by means of feeding tube at a dose of 250 mg / kg body weight.
III. Collection of blood sample
Blood was collected at the beginning and at the end of the experiment retroorbitally from the inner canthus of the eye using micro hematocrit capillaries (Mucaps) in oxalate-sodium fluoride in eppendorf tubes.
IV. Preparation of tissue extracts for enzyme assay.
All animals were sacrificed by cervical dislocation under light ether anesthesia. Immediately after sacrifice, the livers were dissected out, washed in the ice-cold saline, and the homogenates were prepared in Tris HCL buffer (pH 7.4). The homogenate was centrifuged at 3000 rpm for 30 minutes at 4°C in a refrigerated centrifuge (Sorvall RC-5B). The supernatant containing the cytosolic fraction was used for enzyme assays. In the similar way, brain extract and myocardial extract were prepared.
V. Estimation of biochemical parameters. Glucose and glucose tolerance test (GTT)
Glucose was estimated at the beginning and end of the experiment (16 weeks following) by glucose oxidase method using the kit from Ranbaxy Labs, New Delhi India. Standard oral glucose tolerance test was carried out as described by Eshrat Halim.M (13) at the beginning and at the end of 16 weeks of the experiment.
Glycosylated hemoglobin (HbA 1c )
Glycosylated hemoglobin was estimated in the blood by using a kit from Stanger Immunodiagnostics.
Assay of antioxidant enzymes
All the enzyme activities were measured in the supernatant fraction of tissue homogenate separately from liver, heart and brain and the numerical average of three measurements were considered. The activity of total Superoxide dismutase (SOD) was measured by the method of Beers, (14) . The assay of Catalase (CAT) was performed by method of Aebi (15, 16) . Glutathione peroxides (GPX) and Glutathione-S-transferase (GST) activities were estimated by the method of Lawrence and Gupta (17, 18) . Lipid peroxidase (LPO) was determined by the method using the thiobarbituric acid reaction (19) . The amounts of malondialdehyde (MDA) in brain, liver, cardiac and muscle tissue were also estimated by method of Okhawa and Lowry (20, 21) . Erythrocyte catalase and GPX were also measured before treatment and following combined therapy.
Lipid Profile
Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG) were estimated by enzymatic methods employing kits from Orthodiagnostics systems. VLDL and LDL-C level was calculated by the standard formula as described. LDL cholesterol was estimated by using Friedewald WT (1972) formula as follows: LDL in mg % = total cholesterol -(HDL-C -1/5 triglycerides) (22) .
Protein estimation
Protein was estimated according to the method of Lowry et al (20) , using bovine serum albumin as the standard.
VI. Retinal examination
Fluorescein Angiography is the method used to observe retinal blood vessels. Fluoroscein dye was injected into a vein in the leg, as described (23, 24) . The dye travels through the blood vessels including those in eyes. The photograph of the retina was taken at Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi with Zeiss FF 450 plus IR Camera (Carlzeis Meditec AG, 07740 Jena, Germany). A qualified ophthalmologist (acknowledged at the end) carried out the pre -and post-treatment fundus examination.
Statistical Analysis
The data of biochemical parameters were analyzed. Results are presented as mean ± SEM for all experiments. The significance of difference between data pairs was evaluated by analysis of variance (ANOVA) followed by Dunnet's 't' test.
RESULTS

1
Blood glucose : The effects of oral administration of aqueous extract of Tulsi leaves alone and in combination with vitamin E in diabetic rat are shown in Table1. Whereas in diabetic untreated rat plasma glucose continued to rise from 258.9±4.02 mg/dl to 335.7 ±5.99mg/dl, in diabetic rats having treatment with Tulsi alone, plasma glucose fell from 232.4±7.66mg/dl triglyceride levels showed maximum reduction with combined treatment. Table 4 shows the effect of treatment at the end of 16 week on liver enzymes like LPO, SOD, CAT, GPX and GST. While there was remarked reduction of LPO in all treated group as compared to control, there was rise of SOD, CAT, GPX and GST level as an effect of treatment.
Glucose Tolerance Test (GTT) :
LPO and other Antioxidant enzymes :
5.
Erythrocyte GPX and Catalase : Measurement of erythrocyte GPX and catalase activities shows reduction of erythrocyte catalase level (Table 5) following combined therapy.
6.
Malondialdehyde (MDA) in brain, liver and muscle tissue : Table 6 shows MDA level in brain, liver and muscle tissue in normal, diabetic untreated and diabetic rats treated with vitamin E. Without treatment, MDA level rose significantly. Treatment with Vitamin E alone reduced MDA level to near normal.
7.
Retinal changes : Fundus fluorescien angiography of the right eye of diabetic rat shows dot & blot hemorrhages (as indicated by white arrows in Fig.1 ).
Hard exudates (as indicated by black arrows in Fig. 1 ), few cotton wool spots and microaneurysms are also seen. There was also macular edema. Fundoscopic examination following 16 weeks of combination treatment (Vitamin E and Ocimum sanctum) showed complete disappearance of macular edema, hemorrhages and exudates (Fig 2) . The vision also showed remarkable improvement. 
DISCUSSION
Several biochemical mechanisms have been proposed as explanations for progression of diabetic retinopathy. Four major molecular mechanisms have been implicated in hyperglycemia-mediated vascular damage namely, increased polyol pathway flux, increased hexosamine pathway flux, increased AGE formation, and activation of Protein Kinase C (PKC) isoforms through de novo synthesis of the lipid second messenger DAG. Several clinical trials and studies have clearly shown that improved glycemic control is strongly associated with decreased development or regression of diabetic complications in both type I & II DM. Hyperglycemia leads to increased protein glycosylation, which is an important source of free radicals. Garg et al (25) focuses on free radical formation in hyperglycemic conditions. Wolff et al (26) stresses on non-enzymic glycosylation and subsequent browning reaction. Hyperglycemia induced synthesis of diacylglyceral which activates Protein Kinase-C has been highlighted by PKC-DRS study group (27) . Cusick et al (28) has clearly shown that Vitamin E in dietary formulation (in dose of 500 IU daily) could reduce age related eye disease (ARED). Benfotiamine has been shown to block three major pathways of hypoglycemic damage and prevent diabetic retinopathy in experimental animals (29) . Beside hypoglycemic control familial and genetic factors have been stressed to take part in the pathogenesis of complications like nephropathy and retinopathy (30) .
In the present experimental set up of streptozotocin-induced diabetes in rat, hypoglycemic effect of Ocimum sanctum Linn is found to be remarkable (Table 1) . Vitamin-E in this respect is effective but seems to be less potent than Ocimum sanctum Linn. This is consistent with the data already published by Hussain et al (11) , and Sarkar et al (31) . However in 2 hour GTT, Vitamin E is seen to be at least as effective as Ocimum sanctum Linn in reducing blood glucose level ( Table 2 ). Hypolipidemic effect, however, seems to be additive when combined treatment with Ocimum sanctum Linn and Vitamin E are given together (Table 3) . Vitamin E therapy has remarkable effect in reduction of LPO enzyme and elevation of SOD, CAT, GPX and GST (Table 3) . This finding confirms known antioxidant effect of Vitamin E (32). Similar effect of Vitamin E is observed in reduction of malonaldehyde level in liver, brain and myocardial homogenate (Table 6 ).
In the last few years extensive work has been done on antioxidant effects of Ocimum sanctum Linn. Ocimum sanctum pretreatment may also have neuroprotective effect in rat, particular in reperfusion injury (33). Long-term oral feeding of O sanctum, in rats offered significant protection against isoproterenol-induced myocardial necrosis through a unique property of enhancement of endogenous antioxidants (34) . Prior intrapertoneal administration of O sanctum in dose 5 and 10 mg /kg has been shown to have potential anticataract activity in selenite -induced experimental cataractgenesis. Such effect is also supported by concomitant restoration of antioxidant defense system and inhibition of protein insolubilization of rat lenses (35) . Aqueous and alcohol extracts of Ocimum sanctum, have significant in vivo activity against hypercholesterolemia induced lipid peroxidation activity in erythrocyte and provides liver and aortic tissue a kind of protection against hypercholesteroemia-induced peroxidative damage in male albino rats (36) .
Several clinical trials although have clearly shown that improved glycemic control is strongly associated with decreased development or regression of diabetic complication in both types I and II DM (28) , the most remarkable effect of combined therapy with Ocimum sanctum Linn and Vitamin E is, however, seen in diabetic retinopathy. All the features of retinopathy regressed and the vision improved completely. This could be explained by hypoglycemic effect of Ocimum sanctum Linn combined with antioxidant effect of Vitamin E. Given alone, they are not as effective as to cause regression of retinopathic changes as when those are used in combination.
The uniqueness of the present study, therefore, is the demonstration of the effect of combined therapy with Ocimum sanctum Linn and Vitamin E to reverse the changes of diabetic retinopathy.
Treatment of the diabetic animals with Ocimum sanctum Linn and Vitamin E, alone and in combination, for 16 weeks showed reversal of most of the parameters like plasma glucose and lipid levels. Retinal angiography showed remarkable improvement in the retinal changes and in fact reversal of changes following combination treatment.
